Abstract:BackgroundPotassium disorders can cause major complications and must be avoided in critically ill patients. Regulation of potassium in the intensive care unit (ICU) requires potassium administration with frequent blood potassium measurements and subsequent adjustments of the amount of potassium administrated. The use of a potassium replacement protocol can improve potassium regulation. For safety and efficiency, computerized protocols appear to be superior over paper protocols. The aim of this study was to eva… Show more
“…29.5% of the studies occurred in an ICU setting [18,23,31,34-36,39,40,44,47],[51,57-59,63,65,68,73,79,82],[86,88,89], and 15.4% took place in an ED setting [13,20-22,27,29,38,45,75,81],[83,84]. …”
BackgroundHealthcare costs are increasing rapidly and at an unsustainable rate in many countries, and inpatient hospitalizations are a significant driver of these costs. Clinical decision support (CDS) represents a promising approach to not only improve care but to reduce costs in the inpatient setting. The purpose of this study was to systematically review trials of CDS interventions with the potential to reduce inpatient costs, so as to identify promising interventions for more widespread implementation and to inform future research in this area.MethodsTo identify relevant studies, MEDLINE was searched up to July 2013. CDS intervention studies with the potential to reduce inpatient healthcare costs were identified through titles and abstracts, and full text articles were reviewed to make a final determination on inclusion. Relevant characteristics of the studies were extracted and summarized.ResultsFollowing a screening of 7,663 articles, 78 manuscripts were included. 78.2% of studies were controlled before-after studies, and 15.4% were randomized controlled trials. 53.8% of the studies were focused on pharmacotherapy. The majority of manuscripts were published during or after 2008. 70.5% of the studies resulted in statistically and clinically significant improvements in an explicit financial measure or a proxy financial measure. Only 12.8% of the studies directly measured the financial impact of an intervention, whereas the financial impact was inferred in the remainder of studies. Data on cost effectiveness was available for only one study.ConclusionsSignificantly more research is required on the impact of clinical decision support on inpatient costs. In particular, there is a remarkable gap in the availability of cost effectiveness studies required by policy makers and decision makers in healthcare systems.
“…29.5% of the studies occurred in an ICU setting [18,23,31,34-36,39,40,44,47],[51,57-59,63,65,68,73,79,82],[86,88,89], and 15.4% took place in an ED setting [13,20-22,27,29,38,45,75,81],[83,84]. …”
BackgroundHealthcare costs are increasing rapidly and at an unsustainable rate in many countries, and inpatient hospitalizations are a significant driver of these costs. Clinical decision support (CDS) represents a promising approach to not only improve care but to reduce costs in the inpatient setting. The purpose of this study was to systematically review trials of CDS interventions with the potential to reduce inpatient costs, so as to identify promising interventions for more widespread implementation and to inform future research in this area.MethodsTo identify relevant studies, MEDLINE was searched up to July 2013. CDS intervention studies with the potential to reduce inpatient healthcare costs were identified through titles and abstracts, and full text articles were reviewed to make a final determination on inclusion. Relevant characteristics of the studies were extracted and summarized.ResultsFollowing a screening of 7,663 articles, 78 manuscripts were included. 78.2% of studies were controlled before-after studies, and 15.4% were randomized controlled trials. 53.8% of the studies were focused on pharmacotherapy. The majority of manuscripts were published during or after 2008. 70.5% of the studies resulted in statistically and clinically significant improvements in an explicit financial measure or a proxy financial measure. Only 12.8% of the studies directly measured the financial impact of an intervention, whereas the financial impact was inferred in the remainder of studies. Data on cost effectiveness was available for only one study.ConclusionsSignificantly more research is required on the impact of clinical decision support on inpatient costs. In particular, there is a remarkable gap in the availability of cost effectiveness studies required by policy makers and decision makers in healthcare systems.
“…Studies of standardized potassium repletion protocols have not demonstrated a reduction in atrial tachyarrhythmias (14, 15), while multiple trials of magnesium supplementation for POAF prophylaxis have demonstrated no clear benefit (16, 17, 24). Our findings help to explain the lack of efficacy of potassium and magnesium supplementation in these other reports, in that the maintenance of near-normal electrolyte levels was not sufficient to reduce the rate of POAF.…”
Section: Commentmentioning
confidence: 99%
“…The few existing studies of intensive care unit (ICU) electrolyte repletion protocols have demonstrated tighter control of postoperative potassium levels but no effect on the occurrence of POAF (14, 15). Intraoperative and postoperative magnesium administration has also been evaluated as an AF prophylaxis agent in many small and heterogeneous studies, with conflicting but overall limited efficacy (16, 17).…”
Introduction
Despite a lack of demonstrated efficacy, potassium and magnesium supplementation are commonly thought to prevent postoperative atrial fibrillation (POAF) after cardiac surgery. Our aim was to evaluate the natural time course of electrolyte level changes after cardiac surgery and their relationship to POAF occurrence.
Methods
Data were reviewed from 2041 adult patients without preoperative AF who underwent CABG and/or valve surgery between 2009 and 2013. In patients with postoperative AF, the plasma potassium and magnesium levels nearest to the first AF onset time were compared to time-matched electrolyte levels in patients without AF.
Results
POAF occurred in 752 patients (36.8%). At the time of AF onset or the matched time point, patients with POAF had higher potassium (4.30 vs. 4.21 mmol/L, p<0.001) and magnesium (2.33 vs. 2.16 mg/dL, p<0.001) levels than controls. A stepwise increase in AF risk occurred with increasing potassium or magnesium quintile (p<0.001). On multivariate logistic regression analysis, magnesium level was an independent predictor of POAF (OR 4.26, p<0.001), in addition to age, Caucasian race, preoperative beta blocker use, valve surgery, and postoperative pneumonia. Prophylactic potassium supplementation did not reduce the POAF rate (37 vs. 37%, p=0.813), while magnesium supplementation was associated with increased POAF (47 vs. 36%, p=0.005).
Conclusion
Higher serum potassium and magnesium levels were associated with increased risk for POAF after cardiac surgery. Potassium supplementation was not protective against POAF, while magnesium supplementation was even associated with increased POAF risk. These findings help explain the poor efficacy of electrolyte supplementation in POAF prophylaxis.
“…11,12 With regard to electrolyte repletion, numerous studies have focused on the control of a single electrolyte. [13][14][15][16] To date, 4 studies have evaluated repletion protocols for multiple electrolytes in various intensive care settings. [17][18][19][20] The results of these studies have suggested that use of repletion protocols is more effective than standard approaches to electrolyte repletion.…”
Background: Implementation of electrolyte repletion protocols to facilitate and ensure the safety of electrolyte control is common practice in intensive care units (ICUs). However, few protocols have been evaluated and validated.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.